Enhanced Tendon Healing Through Growth Factor and Cell Therapies

通过生长因子和细胞疗法增强肌腱愈合

• 批准号: 9790947
• 负责人: RICHARD H GELBERMAN
• 金额: $ 55.95万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-15 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9790947
• 关键词: Acute; Adhesions; Adipose tissue; Affect; Animals; Ankle; Apoptosis; Articular Range of Motion; Biological; Biomechanics; Canis familiaris; Cell Proliferation; Cell Therapy; Cells; Chronic; Clinical; Coculture Techniques; Connective Tissue; Extracellular Matrix; Fibroblasts; Flexor; Gene Silencing; Genomics; Goals; Growth Factor; Hand; Health Care Costs; Histology; In Vitro; Individual; Inflammation; Inflammatory; Inflammatory Response; Injury; Interleukin-1 beta; Knee; Laceration; Ligaments; Location; MAPK3 gene; Mechanics; Methods; Modeling; Natural regeneration; Operative Surgical Procedures; Outcome; PTK2 gene; Patients; Peptide Hydrolases; Phase; Platelet-Derived Growth Factor; Prevention; Process; Production; Proteomics; Rehabilitation therapy; Rotator Cuff; Rupture; Shoulder; Signal Transduction; Site; Stem cells; Stromal Cells; Structure; Surface; Surgical sutures; Suture Techniques; System; Tendon Injuries; Tendon structure; Testing; Translating; Translations; United States; Up-Regulation; Work; achilles tendon; base; cell growth; cell motility; clinically relevant; connective tissue growth factor; cost; cytokine; disability; efficacy testing; experimental study; healing; improved; in vivo; inflammatory milieu; musculoskeletal injury; novel; novel strategies; recruit; repaired; response; rotator cuff tear; stem cell therapy; success; tissue degeneration; treatment strategy

PROJECT SUMMARY Musculoskeletal injuries in the United States result in significant disability and high costs. Almost half of these injuries are to tendons and ligaments, including lacerations of the flexor tendons of the hand, tears of the Achilles tendon of the ankle, and tears of the rotator cuff of the shoulder. Despite significant advances in suture techniques and rehabilitation methods, outcomes after tendon repair remain unsatisfactory, with high rates of rupture and lost joint range of motion. Therefore, our long-term goal is to develop cell- and growth factor-based strategies to enhance tendon repair. Tendon healing progresses through well-defined stages of inflammation, proliferation, extracellular matrix (ECM) formation, and ECM remodeling. In our prior work, we noted a dramatic upregulation of inflammatory factors in the earliest stage of tendon healing and insufficient cell migration and ECM synthesis in the later stages of tendon healing. Recent stem cell and growth factor studies have demonstrated the potential for biologically augmenting tendon repair. In the current proposal, we will use non- invasive delivery systems to deliver adipose derived stromal cells (ASCs) and the growth factor CTGF to enhance tendon repair. Furthermore, we will elucidate the mechanisms by which ASCs and CTGF affect healing. A cell sheet approach will be used to deliver cells to the tendon surface (suppressing adhesions) and a porous suture approach will be used to deliver growth factors to tendon interior (promoting extracellular matrix synthesis). These new approaches will be tested in a clinically relevant large animal flexor tendon model (although, the approaches will be generally applicable to any tendon surgical repair). Our central hypothesis is that cell therapy will modulate the early inflammatory response and growth factor therapy will modulate the later remodeling response to improve tendon healing. The first specific aim will test the efficacy of ASC cell sheets for enhancing the early inflammatory phase of tendon healing. Previously, we showed that ASCs can modulate tendon responses to inflammation in vitro and in vivo. Despite these observations, the mechanism behind the detrimental effects of inflammatory cytokines on tendon and the translational potential for modulating inflammation via stem cell therapy to enhance healing, have not been fully determined. The second specific aim will test the ability of CTGF to enhance tendon remodeling. In prior work, we demonstrated the potential for tendon regeneration via endogenous stem cell recruitment through the growth factor CTGF. The third aim will evaluate the efficacy of combining ASC cell sheets with suture-based CTGF delivery for enhancing the tendon healing. Based on our in vitro and small animal studies, this aim seeks to enhance tendon healing through simultaneous delivery of CTGF and ASCs to the repair site. If successful, the proposed large animal studies can be directly translated to enhance the treatment of intrasynovial flexor tendon injuries in patients. Furthermore, the results will be broadly applicable to all tendon and ligament surgical repairs (e.g., tendons in the rotator cuff and intrasynovial ligaments in the knee).

项目概要 在美国，肌肉骨骼损伤会导致严重残疾和高昂费用。其中几乎有一半 肌腱和韧带受伤，包括手部屈肌腱撕裂、手部撕裂 脚踝的跟腱和肩部肩袖的撕裂。尽管缝合技术取得了重大进展 由于技术和康复方法的不同，肌腱修复术后的效果仍不理想，修复率较高。 破裂并失去关节活动范围。因此，我们的长期目标是开发基于细胞和生长因子的 增强肌腱修复的策略。肌腱愈合通过明确的炎症阶段进行， 增殖、细胞外基质 (ECM) 形成和 ECM 重塑。在我们之前的工作中，我们注意到一个戏剧性的现象 肌腱愈合早期炎症因子的上调和细胞迁移不足 肌腱愈合后期的 ECM 合成。最近的干细胞和生长因子研究表明 证明了生物增强肌腱修复的潜力。在当前的提案中，我们将使用非 侵入性输送系统将脂肪源性基质细胞 (ASC) 和生长因子 CTGF 输送至 增强肌腱修复。此外，我们将阐明 ASC 和 CTGF 影响的机制 康复。细胞片层方法将用于将细胞递送至肌腱表面（抑制粘连）并 将使用多孔缝合方法将生长因子传递到肌腱内部（促进细胞外 矩阵合成）。这些新方法将在临床相关的大型动物屈肌腱中进行测试 模型（尽管这些方法通常适用于任何肌腱手术修复）。我们的中央 假设细胞疗法将调节早期炎症反应，生长因子疗法将 调节后期的重塑反应以改善肌腱愈合。第一个具体目标将测试其功效 ASC 细胞片可增强肌腱愈合的早期炎症阶段。之前，我们展示了 ASC 可以在体外和体内调节肌腱对炎症的反应。尽管有这些观察结果， 炎症细胞因子对肌腱有害影响的机制及其转化潜力 通过干细胞疗法调节炎症以促进愈合的方法尚未完全确定。这 第二个具体目标将测试 CTGF 增强肌腱重塑的能力。在之前的工作中，我们证明了 通过生长因子 CTGF 募集内源干细胞实现肌腱再生的潜力。 第三个目标将评估将 ASC 细胞片与基于缝合的 CTGF 递送相结合的功效 增强肌腱愈合。基于我们的体外和小动物研究，这一目标旨在增强 通过同时将 CTGF 和 ASC 递送至修复部位来实现肌腱愈合。如果成功的话，建议 大动物研究可直接转化为增强滑膜内屈肌腱损伤的治疗 在患者中。此外，结果将广泛适用于所有肌腱和韧带手术修复（例如， 肩袖肌腱和膝盖滑膜内韧带）。